First Biogen Inc, Now Roche Holding Ltd. : Rays Of Hope For An Alzheimer’s Cure
June 9, 2015 | HANNAH ISHMAEL EST, Bidness Etc
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) is considering the initiation of a second trial to test its investigational Alzheimer’s drug that was abandoned in December after a disappointing initial study, Bloomberg reports. The move comes months after Biogen Inc (NASDAQ:BIIB) reported positive data for its own experimental Alzheimer’s med, BIIB037 ...
read more
Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Nivolumab (Opdivo, Nivolumab BMS) for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer in Previously-Treated Patients
May 22 | PRINCETON, N.J., BUSINESS WIRE
Nivolumab is the first PD-1 immune checkpoint inhibitor to receive a positive opinion ...
read more
FDA Advisory Panel Approves Flibanserin, Experimental 'Viagra For Women'
June 08, 2015 | James Maynard, Tech Times
Flibanserin is being hailed as "Viagra for women." The experimental drug – designed for post-menopausal women with low sex drives – has now won approval from an advisory panel for the Food and Drug Administration (FDA). The FDA previously rejected the female libido pill twice since 2010 over concerns of side effects ...
read more
Insulin produced in Constantine available on market in H1 of 2016
June 6, 2015 | HEALTH - SCIENCE & TECHNOLOGY
On the sidelines of the 75th Session of the American Diabetes Association, the same official said that Constantine insulin production plant will start from the first half of 2016 the production of insulin in vials or in the form of pens. ...